参考文献/References:
[1]刘珊,周翔海,胡萍,等.2型糖尿病患者颈动脉和下肢动脉粥样硬化分级与心脑血管疾病关系的研究[J].中华内分泌代谢杂志,2016,32(12):989-994.[2]Sorensen OE,Borregaard N.Neutrophil extracellular traps—the dark side of neutrophils[J].J Clin Invest,2016,126(5):1612-1620.[3]Li YY,Liu XX,Zhang J,et al.Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma[J].Cancer Biomarkers,2016,16(3):333-342.[4]梁越,张慧文,郑月宏.老年下肢动脉粥样硬化危险因素分析[J].中华老年多器官疾病杂志,2018,17(8):556-564.[5]王欢,胡元会,魏艺,等.动脉粥样硬化病人动脉硬化程度与淋巴细胞、中性粒细胞的相关性研究[J].临床心血管病杂志,2015,31(12):1297.[6]Wang RT,Zhang JR,Li Y,et al.Neutrophil-Lymphocyte ratio is associated with arterial stiffness in diabetic retinopathy in type 2 diabetes[J].J Diabetes Complications,2015,29(2):245-249.[7]李阳,季汉华.中性粒细胞与淋巴细胞比值与非ST段抬高急性冠状动脉综合征及其严重程度关系研究[J].中华临床医师杂志(电子版),2015,7(2):40-43.[8]秦映芬,黄迪迪,周嘉,等.炎症因子与2型糖尿病合并代谢综合征患者亚临床动脉粥样硬化的关系[J].中华内分泌代谢杂志,2016,29(7):592-594.[9]贾啟禹,郭晓燕,侍洪斌,等.中性粒细胞/淋巴细胞比值与2型糖尿病的关联研究[J].中华健康管理学杂志,2015,8(3):177-181.[10]Solak Y,Afsar B,Vaziri ND,et al.Hypertension as an autoimmune and inflam matory disease[J].Hypertens Res,2016,39(8):567-573.[11]张晓会,赵伟,郑晓,等.中性粒细胞与淋巴细胞比值与2型糖尿病微血管病变的相关性研究[J].中华内分泌代谢杂志,2014,30(9):752-754.[12]高祖华,邱夏桑,汤珂珂,等.CD4+CD28 nullT细胞与2型糖尿病患者动脉粥样硬化进展的关系[J].中华医学杂志,2015,95(48):3899-3902.[13]黄婉静,刘清杏,廖永康,等.中性粒细胞与淋巴细胞的比值在早期糖尿病肾病患者中的变化及意义[J].天津医药,2015,43(2):214-216.[14]殷俏,郭淑芹,张云良,等.2型糖尿病及其视网膜病变患者中性粒细胞/淋巴细胞比值变化和意义[J].微循环学杂志,2015,25(4):46-49.[15]严子豪,李想,李博勋.2型糖尿病患者双下肢动脉内膜增厚与糖化血红蛋白、低密度脂蛋白的相关性分析[J].实用老年医学,2015,29(5):378-379,383.[16]刘珊,周翔海,胡萍,等.2型糖尿病患者颈动脉和下肢动脉粥样硬化分级与心脑血管疾病关系的研究[J].中华内分泌代谢杂志,2016,32(12):989-994.[17]杜永明.老年2型糖尿病患者合并动脉粥样硬化的相关因素[J].中国老年学杂志,2014,33(18):4571-4572.[18]唐建东,李清楚,任健,等.初诊2型糖尿病患者血糖控制与中性粒细胞和淋巴细胞比值的相关性[J].实用医学杂志,2015,31(23):3884-3886.[19]顾洪斌.糖尿病下肢动脉病变的特点与外科干预[J].中国医刊,2017,52(2):3-5.[20]梁越,张慧文,郑月宏.老年下肢动脉粥样硬化危险因素分析[J].中华老年多器官疾病杂志,2018,17(8):556-564.[21]Yildiz A,Yuksel M,Oylumlu M,et al.The Utility of the Platelet-Lymphocyte Ratio for Predicting No Reflow in Patients With ST-Segment Elevation Myocardial Infarction[J].Clin Appl Thromb Hemost,2015,21(3):223-228.[22]吴智勇,柳依萌,高小燕,等.不同糖化血红蛋白水平对2型糖尿病患者中性粒细胞/淋巴细胞的影响[J].重庆医学,2017,46(8):1097-1100.[23]Balta S,Celik T,Mikhailidis DP,et al.The Relation between atherosclerosis and the neutrophil-lymphocyte ratio[J].Clin Appl Thromb Hemost,2016,22(5):405-411.[24]何茜,谭洪文,于瑞萍,等.老年2型糖尿病并发冠心病患者血中性粒细胞与淋巴细胞比值的变化及意义[J].中华老年医学杂志,2016,35(3):252-255.[25]张名扬,吕肖锋,张微微,等.2型糖尿病合并急性脑梗死患者血糖波动与颈动脉内中膜厚度的相关性研究[J].解放军医药杂志,2014,25(11):28-31.
相似文献/References:
[1]何晓芳,罗会芹,闫 滢,等.胃癌术后外周血单核细胞、淋巴细胞水平变化对胃癌肝转移患者预后的影响[J].医学信息,2020,33(06):66.[doi:10.3969/j.issn.1006-1959.2020.06.020]
HE Xiao-fang,LUO Hui-qin,YAN Ying,et al.Effects of Changes in Peripheral Blood Mononuclear Cells and Lymphocytes on Gastric Cancer Patients with Liver Metastasis After Operation[J].Medical Information,2020,33(18):66.[doi:10.3969/j.issn.1006-1959.2020.06.020]
[2]刘婕妤,方智辉,李文克,等.伊布替尼与氟达拉滨联合环磷酰胺治疗慢性淋巴细胞白血病的疗效[J].医学信息,2020,33(13):148.[doi:10.3969/j.issn.1006-1959.2020.13.044]
LIU Jie-yu,FANG Zhi-hui,LI Wen-ke,et al.Efficacy of Ibrutinib and Fludarabine Combined with Cyclophosphamide in the Treatment of Chronic Lymphocytic Leukemia[J].Medical Information,2020,33(18):148.[doi:10.3969/j.issn.1006-1959.2020.13.044]
[3]任默涵,于东海,吴 迪.MTHFD2基因在膀胱癌中的表达、功能富集及信号通路的生物信息学分析[J].医学信息,2022,35(24):18.[doi:10.3969/j.issn.1006-1959.2022.24.004]
REN Mo-han,YU Dong-hai,WU Di.Expression, Functional Enrichment and Bioinformatics Analysis of MTHFD2 Gene in Bladder Cancer[J].Medical Information,2022,35(18):18.[doi:10.3969/j.issn.1006-1959.2022.24.004]
[4]勾 熙,叶玉伟,刘 敏,等.血小板与淋巴细胞比值在溃疡性结肠炎患者病情评估中的价值[J].医学信息,2021,34(08):168.[doi:10.3969/j.issn.1006-1959.2021.08.046]
GOU Xi,YE Yu-wei,LIU Min,et al.The Value of the Ratio of Platelets to Lymphocytes in the Evaluation of Patients with Ulcerative Colitis[J].Medical Information,2021,34(18):168.[doi:10.3969/j.issn.1006-1959.2021.08.046]
[5]陆 皓,陈海琳,鲍计章,等.免疫抑制性细胞在免疫性血小板减少症中的作用[J].医学信息,2021,34(13):23.[doi:10.3969/j.issn.1006-1959.2021.13.007]
LU Hao,CHEN Hai-lin,BAO Ji-zhang,et al.The Role of Immunosuppressive Cells in Immune Thrombocytopenia[J].Medical Information,2021,34(18):23.[doi:10.3969/j.issn.1006-1959.2021.13.007]
[6]徐晓雪.CD4单阳参考品辅助检测九色标记人血样品的流式分析技术[J].医学信息,2021,34(20):90.[doi:10.3969/j.issn.1006-1959.2021.20.022]
XU Xiao-xue.Flow Pattern Analysis Technique for CD4 Single-positive Reference Substance-assisted Detection of Nine-color Labeled Human Blood Samples[J].Medical Information,2021,34(18):90.[doi:10.3969/j.issn.1006-1959.2021.20.022]
[7]唐小莉,方长太,陈园园.CD4+T细胞百分比、淋巴细胞对老年脓毒症继发慢重症的临床应用价值[J].医学信息,2023,36(12):102.[doi:10.3969/j.issn.1006-1959.2023.12.019]
TANG Xiao-li,FANG Chang-tai,CHEN Yuan-yuan.The Clinical Application Value of the Percentage of CD4+T Cell and Lymphocyte in Elderly Patients with Chronic Critical Illness After Sepsis[J].Medical Information,2023,36(18):102.[doi:10.3969/j.issn.1006-1959.2023.12.019]
[8]焦 燕,夏海龙,张舒颖.全身炎症反应指数对多发性骨髓瘤患者疗效及预后的评估价值[J].医学信息,2024,37(05):96.[doi:10.3969/j.issn.1006-1959.2024.05.016]
JIAO Yan,XIA Hai-long,ZHANG Shu-ying.Value of Systemic Inflammation Response Index for the Efficacy and Prognostic Evaluation of Multiple Myeloma Patients[J].Medical Information,2024,37(18):96.[doi:10.3969/j.issn.1006-1959.2024.05.016]
[9]汪 琴,方长太,陈园园.N/LP对脓毒症AKI患者预后的评估价值及其与罗氏AKI评分的相关性[J].医学信息,2021,34(19):113.[doi:10.3969/j.issn.1006-1959.2021.19.029]
WANG Qin,FANG Chang-tai,CHEN Yuan-yuan.Prognostic Value of N/LP in Septic AKI Patients and its Correlation with Roche AKI Score[J].Medical Information,2021,34(18):113.[doi:10.3969/j.issn.1006-1959.2021.19.029]
[10]贾鹏飞,崔海燕,胡宝荣.中性粒细胞与淋巴细胞和血小板乘积的比值对重症肺炎患者短期生存状态的预测价值[J].医学信息,2022,35(15):79.[doi:10.3969/j.issn.1006-1959.2022.15.017]
JIA Peng-fei,CUI Hai-yan,HU Bao-rong.The Predictive Value of Neutrophil to Lymphocyte and Platelet Ratio for Short-term Survival in Patients with Severe Pneumonia[J].Medical Information,2022,35(18):79.[doi:10.3969/j.issn.1006-1959.2022.15.017]